- Company
- The development of Kcav's Mucovac is in full swing
- by Dec 27, 2021 05:57am
- A spray-type COVID-19 vaccine sprayed on the nose, not on injections, is being developed by domestic company. Amid the trend of muscle injection, attention is focused on claims that mucosal immunity is more effective in defending the COVID-19 virus. Kcav (CEO Song Chang-seon) announced on the 27th that Mucovac, a COVID-19 mucosal vaccine cand
- Company
- To introduce a phase 3 clinical drug preferential policy
- by Nho, Byung Chul Dec 27, 2021 05:56am
- Attention is focusing on whether the industry, the National Assembly, and the MOHW will be able to derive a reasonable and efficient institutional direction in relation to the "policy for preferential treatment of new drugs in phase 3 clinical trials for Koreans." According to related industries on the 23rd, after the drug preferential reg
- Company
- Reimb of SGLT-2i combos unclear... nears PMS expiry
- by Eo, Yun-Ho Dec 24, 2021 05:49am
- Anticipation has turned to tension. The companies that own SGLT-2 and DPP-2 combination therapies are facing hardships ahead of their post-marketing surveillance period expiry. At the diabetes expert meeting that was held by the Health Insurance Review and Assessment Service in September, the members concluded that the authorities should
- Company
- GI Innovation·A/Z, a study on immuno-cancer drugs combined
- by Nho, Byung Chul Dec 24, 2021 05:48am
- GI Innovation (CEO Hong Joon-ho) announced on the 17th that it has signed a clinical supply contract with AstraZeneca in the UK to develop a combination therapy with GI-101, an immuno-cancer drug, and Impinzi (Durvalumab). With this contract, GI Innovation will conduct clinical trials with AstraZeneca to evaluate the combination of immuno-can
- Company
- MSD's Delstrigo can be prescribed in general hospitals
- by Eo, Yun-Ho Dec 23, 2021 05:42am
- Delstrigo, an HIV combination that succeeded in registering insurance benefits, is preparing to enter the market in earnest. According to related industries, the HIV combination Delstrigo ( Doravirine 100 mg, Lamivudine 300 mg and Tenofir Disoproxil Fumarate), which is taken once a day by MSD Korea, has now passed the DC of medical instituti
- Company
- [2021 Pharmaceutical Patent Settlement] The target is Dukarb
- by Kim, Jin-Gu Dec 23, 2021 05:41am
- Generics' challenge was found to have been concentrated on patents for Boryung's hypertension complex "Dukarb," Novartis' heart failure treatment "Entresto," and Hanmi Pharmaceutical's asthma treatment "Monterizine. The number of companies targeting the patent alone amounts to 45 Dukarb companies, 24 Entresto companies, and 22 Monterizine compan
- Company
- MNC employees enjoy 17 days maximum as year-end holidays
- by Eo, Yun-Ho Dec 22, 2021 05:57am
- As in any year, the multinational pharmaceutical companies are again closing down for a long-term year-end holiday. According to Dailypharm’s research of 23 major pharmaceutical companies in Korea, 6 companies have set a 10-day or longer year-end holiday. Also, more than 10 pharmaceutical companies will be closing down for nine days.
- Company
- JW Pharm to discuss technical partnerships for its gout Tx
- by Lee, Seok-Jun Dec 22, 2021 05:56am
- JW Pharmaceutical will be discussing technical partnerships for its key new drug candidates such as URC102 and JW2286 with global pharmaceutical companies. On the 20th, JW Pharmaceutical announced that it will be attending the ‘2022 JP Morgan Healthcare Conference’ that will be held online from the 10th next month (local time) and intr
- Company
- "MET-targeted therapy as a new personalized NSCLC solution"
- by Eo, Yun-Ho Dec 21, 2021 06:05am
- HER2, ALK, EGFR, ROS1, NTRK. These keywords have been frequent visitors in articles on anticancer drugs recently. With the discovery that effective anticancer treatments differ depending on the patient’s genetic mutation status, personalized treatments that target specific genes of each individual are being introduced. And the developmen
- Company
- Is there a shortage of chickenpox vaccines?
- by Moon, sung-ho Dec 21, 2021 06:05am
- Contrary to the opinions of the medical community, SK Bio and GC Pharma said, "There is no problem in supplying chickenpox vaccines." The shortage of influenza (flu) vaccines in the second half of this year is causing confusion due to concerns that chickenpox vaccines may also be insufficient. Pharmaceutical and bio companies that produce chicke
